LOPROX
LOE ApproachingNDATOPICALSHAMPOO
Approved
Feb 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 23h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOPROX is a topical antifungal shampoo approved by the FDA in 2003 for the treatment of fungal scalp infections and seborrheic dermatitis. The product is formulated for direct application to the scalp and hair, providing localized antifungal therapy. Generic name and mechanism of action data are not currently available in the product record.
LOE Approaching
As LOE approaches, the brand team is likely operating in maintenance mode with reduced headcount and focus on generic transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
LOPROX offers limited career advancement opportunities given its LOE-approaching status and zero linked job openings. Working on this product typically involves managing decline, supporting generic transition, and maintaining existing customer relationships rather than driving growth or innovation.
Brand ManagerField Sales Representative
Worked on LOPROX at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.